{"id":80014,"date":"2024-12-03T16:23:43","date_gmt":"2024-12-03T16:23:43","guid":{"rendered":"https:\/\/www.cofb.org\/?p=80014"},"modified":"2024-12-03T16:36:11","modified_gmt":"2024-12-03T16:36:11","slug":"la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","title":{"rendered":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat"},"content":{"rendered":"\n

El passat 14 de novembre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) <\/strong>va organitzar, juntament amb la Fundaci\u00f3 Oncolliga<\/a>, la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\u201d <\/strong>amb el patrocini de Johnson & Johnson<\/a>. La sessi\u00f3, moderada pel tresorer del COFB, Miquel Recasens<\/strong>, va anar a c\u00e0rrec de la Dra.<\/strong> Enriqueta Felip<\/strong>, cap de la secci\u00f3 d\u2019Oncologia M\u00e8dica de la Unitat de Tumors Tor\u00e0cics de la Vall d\u2019Hebron de Barcelona; Gemma Puig<\/strong>, farmac\u00e8utica, t\u00e8cnica de l’\u00c0rea del Medicament del Departament de Salut; Maria Assumpci\u00f3 Vil\u00e0<\/strong>, presidenta de la Fundaci\u00f3 Oncolliga; i la Dra. \u00c0ngels Arcusa<\/strong>, presidenta del Comit\u00e8 Cient\u00edfic de la Fundaci\u00f3 Oncolliga.<\/p>\n\n\n\n

\"\"<\/a>
D’esquerra a dreta: la Dra. Enriqueta Felip, Gemma Puig i Miquel Recasens. <\/figcaption><\/figure>\n\n\n\n

Els objectius <\/strong>de la tert\u00falia d\u2019actualitat van ser identificar les caracter\u00edstiques<\/strong> i tipus de c\u00e0ncers de pulm\u00f3<\/strong>, con\u00e8ixer les tend\u00e8ncies<\/strong> i aven\u00e7os cient\u00edfics<\/strong> en el c\u00e0ncer de pulm\u00f3, revisar les novetats terap\u00e8utiques<\/strong> i promoure les estrat\u00e8gies de prevenci\u00f3<\/strong>.<\/p>\n\n\n\n

La Dra. \u00c0ngels Arcusa<\/strong>, presidenta del Comit\u00e8 Cient\u00edfic de la Fundaci\u00f3 Oncolliga va iniciar la tert\u00falia d\u2019actualitat explicant quina \u00e9s la missi\u00f3 principal de la Fundaci\u00f3<\/strong>: \u201c\u00e9s un conjunt de persones al servei d\u2019altres persones; el que es pret\u00e9n \u00e9s acompanyar i ajudar als pacients amb c\u00e0ncer i a les seves fam\u00edlies<\/strong>\u201d. La doctora va fer especial \u00e8mfasi en el fet que el c\u00e0ncer no \u00e9s una malaltia d\u2019una sola persona sin\u00f3 que \u201cemmalalteix i ho pateixen totes aquelles persones que l\u2019envolten<\/strong>\u201d. Per tant, l\u2019objectiu de la Fundaci\u00f3 Oncolliga, segons va indicar la Dra. Arcusa, \u00e9s fer actuacions de \u201cdifusi\u00f3, comunicaci\u00f3, informaci\u00f3, conscienciaci\u00f3 del c\u00e0ncer i del que representa en la nostra societat, en tot el que s\u00f3n les mesures de prevenci\u00f3, de tractament i d\u2019acompanyament\u201d.<\/p>\n\n\n\n

\"La<\/a>
La Dra. \u00c0ngels Arcusa i Miquel Recasens en un moment de la confer\u00e8ncia. <\/figcaption><\/figure>\n\n\n\n

Espec\u00edficament sobre el c\u00e0ncer de pulm\u00f3<\/strong>, la Dra. \u00c0ngels Arcusa, va assegurar que en els darrers 20-22 anys, el c\u00e0ncer de pulm\u00f3 \u201cha fet un canvi de 180\u00b0\u201d, ja que \u201cd\u2019una malaltia que pr\u00e0cticament no f\u00e8iem gaireb\u00e9 seguiment perqu\u00e8 els pacients morien als quatre, cinc, sis mesos, hem passat a llargues superviv\u00e8ncies d\u2019anys incl\u00fas en malalts metast\u00e0tics i tamb\u00e9 hem cronificat aquesta malaltia<\/strong>\u201d.<\/p>\n\n\n\n

Aven\u00e7os cient\u00edfics i prevenci\u00f3 en el c\u00e0ncer de pulm\u00f3<\/strong><\/h2>\n\n\n\n

A continuaci\u00f3, va intervenir la Dra.<\/strong> Enriqueta Felip<\/strong>, cap de la secci\u00f3 d\u2019Oncologia M\u00e8dica de la Unitat de Tumors Tor\u00e0cics de la Vall d\u2019Hebron de Barcelona, que va profunditzar en el c\u00e0ncer de pulm\u00f3 <\/strong>pel que fa als aven\u00e7os cient\u00edfics<\/strong> i la prevenci\u00f3 d\u2019aquesta malaltia<\/strong>. \u201cEl c\u00e0ncer de pulm\u00f3 \u00e9s una malaltia d\u2019elevada incid\u00e8ncia<\/strong>, ja que \u00e9s el segon c\u00e0ncer m\u00e9s diagnosticat en el m\u00f3n<\/strong> i \u00e9s la principal causa de mort per c\u00e0ncer<\/strong>\u201d. La doctora va detallar la incid\u00e8ncia i mortalitat d\u2019aquest c\u00e0ncer a Espanya, les principals \u00e0rees d\u2019intervenci\u00f3, els cinc factors de risc evitables, dos estudis de cribratges de c\u00e0ncer de pulm\u00f3, els reptes que suposa la implementaci\u00f3 del cribratge i l\u2019abordatge multidisciplinari del c\u00e0ncer.<\/p>\n\n\n\n

\"La<\/a>
La Dra. Enriqueta Felip durant la seva exposici\u00f3. <\/figcaption><\/figure>\n\n\n\n

Per tancar la seva presentaci\u00f3, la Dra. Felip, va remarcar que \u201ccal garantir que el pacient tingui en tot moment: agilitat en els processos<\/strong>, comunicaci\u00f3<\/strong> amb els professionals, informaci\u00f3 clara <\/strong>sobre opcions de tractament<\/strong> i pron\u00f2stic<\/strong>, informaci\u00f3<\/strong> sobre els efectes secundaris<\/strong> i sobre els h\u00e0bits de vida<\/strong> recomanats i suport integral<\/strong>\u201d.<\/p>\n\n\n\n

Els nous medicaments per tractar el c\u00e0ncer de pulm\u00f3<\/strong><\/h2>\n\n\n\n

A continuaci\u00f3, la farmac\u00e8utica i t\u00e8cnica de l’\u00c0rea del Medicament del Departament de Salut, Gemma Puig<\/strong>, va especificar quins s\u00f3n els nous f\u00e0rmacs per tractar el c\u00e0ncer de pulm\u00f3<\/strong>. Aix\u00ed doncs, la farmac\u00e8utica va oferir una visi\u00f3 general de les novetats recents<\/strong>, de l\u2019autoritzaci\u00f3<\/strong> i acc\u00e9s als medicaments<\/strong> i els nous reptes que es plantegen<\/strong>.<\/p>\n\n\n\n

\"Gemma<\/a>
Gemma Puig impartint la seva confer\u00e8ncia sobre els nous medicaments per tractar el c\u00e0ncer de pulm\u00f3.<\/figcaption><\/figure>\n\n\n\n

Puig va comentar que hi ha hagut molta innovaci\u00f3 en el c\u00e0ncer de pulm\u00f3<\/strong>; \u201cdes de finals de 2023 fins a l\u2019octubre de 2024, s\u2019han autoritzat 12 indicacions<\/strong>\u201d.  Alhora, va ressaltar que “hi ha una evoluci\u00f3 del tractament del c\u00e0ncer de pulm\u00f3<\/strong> cap a l\u2019abordatge de l\u2019estadi preco\u00e7, per\u00f2 tamb\u00e9 en primera l\u00ednia metast\u00e0tica\u201d. En darrer lloc, va remarcar que \u201cl\u2019elevat cost dels nous tractaments pot comprometre a sostenibilitat del sistema\u201d, per aix\u00f2, va dir que \u201ccal trobar l\u2019equilibri entre aquests aven\u00e7os terap\u00e8utics i aquestes millores amb la sostenibilitat del sistema\u201d.<\/p>\n\n\n\n

Import\u00e0ncia del suport en el malalt oncol\u00f2gic<\/strong><\/h2>\n\n\n\n

Finalment, la presidenta de la Fundaci\u00f3 Oncolliga, Maria Assumpci\u00f3 Vil\u00e0<\/strong>, va cloure la tert\u00falia d\u2019actualitat. \u201cAnys enrere quan sent\u00edem parlar de c\u00e0ncer de pulm\u00f3, l\u2019associ\u00e0vem directament amb la mort\u201d<\/strong>, va indicar Vil\u00e0, que va afegir que, en l\u2019actualitat, \u201chi ha moltes esperances\u201d<\/strong>. En aquest sentit, va destacar la import\u00e0ncia de la recerca.<\/p>\n\n\n\n

\"\"<\/a>
Maria Assumpci\u00f3 Vil\u00e0 i Miquel Recasens durant la tert\u00falia d’actualitat.<\/figcaption><\/figure>\n\n\n\n

\u201cLes fundacions com Oncolliga estem aqu\u00ed per ajudar a aquelles persones que han patit o pateixen la malaltia oferint suport social, psicol\u00f2gic i t\u00e8cnic<\/strong>\u201d, va recordar Vil\u00e0.<\/p>\n\n\n\n

<\/div>
\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div>\n

Coorganitza:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div><\/section>\n\n\n\n
<\/div>
\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div>\n

Patrocina:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div><\/section>\n","protected":false},"excerpt":{"rendered":"

El passat 14 de novembre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar, juntament amb la Fundaci\u00f3 Oncolliga, la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\u201d amb el patrocini de Johnson & Johnson. La sessi\u00f3, moderada pel tresorer del COFB, Miquel Recasens, va anar a […]<\/p>\n","protected":false},"author":3,"featured_media":80024,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[64,5181,723,5182,18,19,53,68,69,70,76,724,59,264,140],"class_list":["post-80014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica","tag-avencos-cientifics","tag-cancer","tag-cancer-pulmo","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-formacio","tag-oficina-de-farmacia","tag-oncologia","tag-pacients","tag-prevencio","tag-tertulia-dactualitat"],"yoast_head":"\nLa prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3"\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-03T16:23:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-03T16:36:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat\",\"datePublished\":\"2024-12-03T16:23:43+00:00\",\"dateModified\":\"2024-12-03T16:36:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\"},\"wordCount\":954,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"aven\u00e7os cient\u00edfics\",\"c\u00e0ncer\",\"c\u00e0ncer pulm\u00f3\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"Oficina de farm\u00e0cia\",\"oncologia\",\"pacients\",\"prevenci\u00f3\",\"tert\u00falia d'actualitat\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\",\"url\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\",\"name\":\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"datePublished\":\"2024-12-03T16:23:43+00:00\",\"dateModified\":\"2024-12-03T16:36:11+00:00\",\"description\":\"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\\\"\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"width\":2560,\"height\":1440,\"caption\":\"La Dra. Enriqueta Felip en un moment de la seva exposici\u00f3.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","og_locale":"ca_ES","og_type":"article","og_title":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\"","og_url":"https:\/\/www.cofb.org\/ca\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2024-12-03T16:23:43+00:00","article_modified_time":"2024-12-03T16:36:11+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Berta Mart\u00ednez","Temps estimat de lectura":"7 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat","datePublished":"2024-12-03T16:23:43+00:00","dateModified":"2024-12-03T16:36:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/"},"wordCount":954,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","keywords":["Atenci\u00f3 farmac\u00e8utica","aven\u00e7os cient\u00edfics","c\u00e0ncer","c\u00e0ncer pulm\u00f3","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","Oficina de farm\u00e0cia","oncologia","pacients","prevenci\u00f3","tert\u00falia d'actualitat"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","url":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","name":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","datePublished":"2024-12-03T16:23:43+00:00","dateModified":"2024-12-03T16:36:11+00:00","description":"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\"","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","width":2560,"height":1440,"caption":"La Dra. Enriqueta Felip en un moment de la seva exposici\u00f3."},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 14 de novembre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar, juntament amb la Fundaci\u00f3 Oncolliga, la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\u201d amb el patrocini de Johnson & Johnson. La sessi\u00f3, moderada pel tresorer del COFB, Miquel Recasens, va anar a […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/80014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=80014"}],"version-history":[{"count":38,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/80014\/revisions"}],"predecessor-version":[{"id":80069,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/80014\/revisions\/80069"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/80024"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=80014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=80014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=80014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}